Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma release_mz2f4lhn5zgozh4ihoqsyjteca

by Hira S. Mian, Tanya M. Wildes, Mark A. Fiala

References

NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 28 of 28 references (in 109ms)
[1]

via fatcat-pubmed
Frailty in elderly people
Andrew Clegg, John Young, Steve Iliffe, Marcel Olde Rikkert, Kenneth Rockwood
2013   The Lancet
doi:10.1016/s0140-6736(12)62167-9  pmcid:PMC4098658  pmid:23395245 
web.archive.org [PDF]
[2]

via fatcat-pubmed
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Raquel de Paz, José García-Laraña, Enrique Bengoechea (+ more)
2010   The Lancet Oncology
doi:10.1016/s1470-2045(10)70187-x  pmid:20739218 
[3]

via fatcat-pubmed
Improved survival in multiple myeloma and the impact of novel therapies
S. K. Kumar, S. V. Rajkumar, A. Dispenzieri, M. Q. Lacy, S. R. Hayman, F. K. Buadi, S. R. Zeldenrust, D. Dingli (+ more)
2007   Blood
doi:10.1182/blood-2007-10-116129  pmcid:PMC2254544  pmid:17975015 
web.archive.org [PDF]
[4]

via fatcat-pubmed
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial
Cyrille Hulin, Andrew Belch, Chaim Shustik, Maria Teresa Petrucci, Ulrich Dührsen, Jin Lu, Kevin Song, Philippe Rodon (+ more)
2016   Journal of Clinical Oncology
doi:10.1200/jco.2016.66.7295  pmid:27325857 
[5]

via fatcat-pubmed
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
A. Palumbo, S. Bringhen, H. Ludwig, M. A. Dimopoulos, J. Blade, M. V. Mateos, L. Rosinol, M. Boccadoro (+ more)
2011   Blood
doi:10.1182/blood-2011-06-358812  pmid:21841166 
web.archive.org [PDF]
[6]

via fatcat-pubmed
Development of a frailty index for older people with intellectual disabilities: Results from the HA-ID study
Josje D. Schoufour, Arnold Mitnitski, Kenneth Rockwood, Heleen M. Evenhuis, Michael A. Echteld
2013   Research in Developmental Disabilities
doi:10.1016/j.ridd.2013.01.029  pmid:23475005 
[7]

via fatcat-pubmed
Accumulation of Deficits as a Proxy Measure of Aging
Arnold B. Mitnitski, Alexander J. Mogilner, Kenneth Rockwood
2001   The Scientific World Journal
doi:10.1100/tsw.2001.58  pmcid:PMC6084020  pmid:12806071 
web.archive.org [PDF]
[8]

via fatcat-pubmed
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy
Harvey Jay Cohen, David Smith, Can-Lan Sun, William Tew, Supriya G. Mohile, Cynthia Owusu, Heidi D. Klepin, Cary P. Gross (+ more)
2016   Cancer
doi:10.1002/cncr.30269  pmcid:PMC5138076  pmid:27529755 
web.archive.org [PDF]
[9]

via fatcat-pubmed
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Monika Engelhardt, Anne-Saskia Domm, Sandra Maria Dold, Gabriele Ihorst, Heike Reinhardt, Alexander Zober, Stefanie Hieke, Corine Baayen (+ more)
2017   Haematologica
doi:10.3324/haematol.2016.162693  pmcid:PMC5477610  pmid:28154088 
web.archive.org [PDF]
[10]

via fatcat-pubmed
Cumulative index of health disorders as an indicator of aging-associated processes in the elderly: Results from analyses of the National Long Term Care Survey
A. Kulminski, A. Yashin, K. Arbeev, I. Akushevich, S. Ukraintseva, K. Land, K. Manton
2007   Mechanisms of Ageing and Development
doi:10.1016/j.mad.2006.12.004  pmcid:PMC1866299  pmid:17223183 
[11]

via fatcat-pubmed
Using an accumulation of deficits approach to measure frailty in a population of home care users with intellectual and developmental disabilities: an analytical descriptive study
Katherine McKenzie, Hélène Ouellette-Kuntz, Lynn Martin
2015   BMC Geriatrics
doi:10.1186/s12877-015-0170-5  pmcid:PMC4683739  pmid:26678519 
web.archive.org [PDF]
[12]

via fatcat-pubmed
The frailty index in Europeans: association with age and mortality
Roman Romero-Ortuno, Rose Anne Kenny
2012   Age and Ageing
doi:10.1093/ageing/afs051  pmcid:PMC3424051  pmid:22522775 
web.archive.org [PDF]
[13]

via fatcat-pubmed
Frailty, fitness and late-life mortality in relation to chronological and biological age
Arnold B Mitnitski, Janice E Graham, Alexander J Mogilner, Kenneth Rockwood
2002   BMC Geriatrics
doi:10.1186/1471-2318-2-1  pmcid:PMC88955  pmid:11897015 
web.archive.org [PDF]
[14]

via fatcat-pubmed
Heterogeneity of Human Aging and Its Assessment
Arnold Mitnitski, Susan E. Howlett, Kenneth Rockwood
2016   The journals of gerontology. Series A, Biological sciences and medical sciences
doi:10.1093/gerona/glw089  pmcid:PMC5458417  pmid:27216811 
web.archive.org [PDF]
[15]

via fatcat-pubmed
Development and validation of a frailty index in the Longitudinal Aging Study Amsterdam
Emiel O. Hoogendijk, Olga Theou, Kenneth Rockwood, Bregje D. Onwuteaka-Philipsen, Dorly J. H. Deeg, Martijn Huisman
2016   Aging Clinical and Experimental Research
doi:10.1007/s40520-016-0689-0  pmcid:PMC5589777  pmid:27896796 
web.archive.org [PDF]
[16]

via fatcat-pubmed
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
A. Palumbo, S. Bringhen, M.-V. Mateos, A. Larocca, T. Facon, S. K. Kumar, M. Offidani, P. McCarthy (+ more)
2015   Blood
doi:10.1182/blood-2014-12-615187  pmcid:PMC4375104  pmid:25628469 
web.archive.org [PDF]
[17]

via fatcat-pubmed
Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey
K. Rockwood, X. Song, A. Mitnitski
2011   CMAJ - Canadian Medical Association Journal
doi:10.1503/cmaj.101271  pmcid:PMC3091935  pmid:21540166 
web.archive.org [PDF]
[18]

via fatcat-pubmed
Frailty in Relation to the Accumulation of Deficits
K. Rockwood, A. Mitnitski
2007   The journals of gerontology. Series A, Biological sciences and medical sciences
doi:10.1093/gerona/62.7.722  pmid:17634318 
[19]

via fatcat-pubmed
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
A. J. Waxman, P. J. Mink, S. S. Devesa, W. F. Anderson, B. M. Weiss, S. Y. Kristinsson, K. A. McGlynn, O. Landgren
2010   Blood
doi:10.1182/blood-2010-07-298760  pmcid:PMC3031400  pmid:20823456 
web.archive.org [PDF]
[20]

via fatcat-pubmed
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S K Kumar, A Dispenzieri, M Q Lacy, M A Gertz, F K Buadi, S Pandey, P Kapoor, D Dingli (+ more)
2013   Leukemia
doi:10.1038/leu.2013.313  pmcid:PMC4000285  pmid:24157580 
web.archive.org [PDF]
[21]

via fatcat-pubmed
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis
Samantha Pozzi, Luigi Marcheselli, Alessia Bari, Eliana V. Liardo, Raffaella Marcheselli, Stefano Luminari, Micol Quaresima, Claudia Cirilli (+ more)
2013   British Journal of Haematology
doi:10.1111/bjh.12465  pmid:23889344 
[22]

via fatcat-pubmed
Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores
M. Engelhardt, S. M. Dold, G. Ihorst, A. Zober, M. Moller, H. Reinhardt, S. Hieke, M. Schumacher (+ more)
2016   Haematologica
doi:10.3324/haematol.2016.148189  pmcid:PMC5060028  pmid:27479825 
web.archive.org [PDF]
[23]

via fatcat-pubmed
Multiple Myeloma
Antonio Palumbo, Kenneth Anderson
2011   New England Journal of Medicine
doi:10.1056/nejmra1011442  pmid:21410373 
web.archive.org [PDF]
[24]

via fatcat-pubmed
How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program
Jason Brown, Mark Duggan, Ilyana Kuziemko, William Woolston
2014   The American Economic Review
pmid:29533567 
[25]

via fatcat-pubmed
A standard procedure for creating a frailty index
Samuel D Searle, Arnold Mitnitski, Evelyne A Gahbauer, Thomas M Gill, Kenneth Rockwood
2008   BMC Geriatrics
doi:10.1186/1471-2318-8-24  pmcid:PMC2573877  pmid:18826625 
web.archive.org [PDF]
[26]

via fatcat-pubmed
Derivation of a frailty index from the interRAI acute care instrument
Ruth E Hubbard, Nancye M Peel, Mayukh Samanta, Leonard C Gray, Brant E Fries, Arnold Mitnitski, Kenneth Rockwood
2015   BMC Geriatrics
doi:10.1186/s12877-015-0026-z  pmcid:PMC4373301  pmid:25887105 
web.archive.org [PDF]
[b26]

via fuzzy
How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program
Jason Brown, Mark Duggan, Ilyana Kuziemko, William Woolston
2014   The American Economic Review
doi:10.1257/aer.104.10.3335 
web.archive.org [PDF]
[b27]

via grobid
Clegg A, Young J, Iliffe S, et al: Frailty in elderly people. Lancet 381:752-762, 2013